Fusion energy
Highlights
- Fusion is becoming a platform technology sector, as much as an energy sector, generating intellectual property with relevance far beyond future fusion power plants.
- Plasma technologies developed for fusion share strong technological overlap with semiconductor fabrication and spacecraft propulsion, creating opportunities for technology transfer and collaboration.
- High-temperature superconducting (HTS) magnet technologies developed for fusion, have potential applications in MRI systems, power transmission, data centres, particle accelerators and other advanced industrial systems.
- Tritium fuel-cycle innovations are increasingly being applied beyond energy generation, particularly in healthcare and isotope production, where techniques for handling and processing hydrogen isotopes have significant commercial value.
- Fusion companies are increasingly protecting inventions with applications across multiple sectors, broadening opportunities for licensing, partnerships and earlier commercial returns.
Market context
Fusion energy is benefiting from a more supportive policy and investment environment than at any point in recent years. Broader efforts to expand nuclear generation capacity, including commitments to triple global nuclear capacity by 2050, have coincided with renewed government support for advanced reactor technologies, fusion programmes and fuel-cycle innovation.
Fusion research is inherently multidisciplinary. Delivering practical fusion energy requires breakthroughs across plasma physics, superconducting materials, advanced manufacturing, control systems, isotope handling, cryogenics and numerous other technical fields. Many of these technologies have applications in markets that are already established and considerably closer to commercial deployment than fusion power itself.
As a result, the fusion innovation landscape represents a rich source of intellectual property, licensing opportunities and potential spin-outs with relevance across sectors including semiconductors, healthcare, aerospace, energy infrastructure and advanced manufacturing. Examining patent activity in key fusion technology areas therefore provides insight not only into the future of energy generation, but also into where commercial opportunities may emerge in adjacent industries.
Plasma generation, handling and diagnostic
In fusion reactors, fuel consisting of hydrogen isotopes is heated to temperatures of more than 100 million degrees, hotter than the core of the sun, creating a plasma. The ionised particles in the plasma collide and fuse, releasing large amounts of energy. No material can withstand direct contact with plasma at these high temperatures, and so powerful magnetic fields are used to confine the plasma.
Confining the plasma and maintaining its stability over sustained periods poses one of the most complex challenges in fusion energy. This requires highly sophisticated control systems that continuously monitor the plasma and can manage instabilities in real time and ensuring efficient confinement.
Figure 1: 10-year trend (2015-2024) - global patent priority filings in plasma generation and handling by year
Patent filings relating to plasma generation and handling have remained relatively stable over the past two decades, fluctuating around a consistent baseline before declining to 913 in 2024. This indicates that innovation in this area remains important but is not currently experiencing rapid expansion.
However, the patent landscape suggests that plasma technologies are valuable far beyond fusion. In plasma generation and handling, semiconductor equipment suppliers and semiconductor manufacturers account for approximately 70% of patent families over the past twenty years, while dedicated fusion companies and fusion-focused research institutes account for only a small proportion.
Tokyo Electron is the clear leader, followed by Applied Materials, while LAM Research remains another significant filer. This reflects the importance of plasma technologies in semiconductor fabrication and highlights the extent of cross-sector innovation.
Figure 2: 10-year trend (2016-2025) - top filers in plasma generation and handling
The increasingly multidisciplinary nature of plasma innovation is also evident in filing activity across different application areas.
Plasma diagnostics generated 65 priority filings in 2024, more than double the 30 classified directly as fusion and well ahead of space applications (35), although down from a peak of 114 in 2022.
Figure 3: 10-year trend (2015-2024) - priority filings in plasma diagnostics, fusion and space applications
The comparable levels of patenting in fusion and space-related plasma technologies suggest a genuine technological adjacency rather than a niche overlap.
Electric propulsion systems, including ion and Hall-effect thrusters used by satellites and deep-space missions, rely on precise manipulation of plasma to generate thrust. Advances in plasma confinement, diagnostics and control developed for fusion reactors could therefore improve spacecraft propulsion systems where fuel efficiency is critical.
Our analysis of recent filings indicates that fusion organisations are increasingly recognising these opportunities. Some fusion companies are pursuing patent claims that are not restricted to fusion implementations and instead seek protection for broader plasma-control technologies.
Others are explicitly identifying aerospace applications in their specifications. Similarly, fusion research institutes are filing patent applications relating to plasma equipment for semiconductor manufacturing, indicating meaningful technology transfer between fusion research and semiconductor processing.
Tritium fuel-cycle technologies
Tritium, a hydrogen isotope, is a key fuel in many proposed fusion reactor designs. However, tritium is extremely scarce in nature and so, for fusion to become a practical source of clean energy, a sustainable tritium fuel cycle is essential. Reactors must be capable of breeding, recovering and efficiently recycling their own fuel.
Building this closed-loop fuel cycle requires sophisticated systems capable of breeding, tracking, separating, purifying, recovering, storing and recycling hydrogen isotopes with high precision and safety. Operating reliably in harsh environments while minimising losses has made tritium handling one of fusion's most significant innovation challenges.
Patent priority filings covering tritium breeding, extraction, processing and monitoring rose from 47 in 2020 to 77 in 2024, the highest level recorded since 2005 and well above the level typically seen throughout much of the 2000s. Our analysis identifies a clear step change after 2020, suggesting that fuel-cycle challenges are becoming a major focus of fusion-related innovation.
Figure 4: 10-year trend (2015-2024) - priority filings in tritium breeding, extraction, processing and monitoring
The growth is not confined solely to fusion applications. Healthcare has emerged as one of the most significant adjacent sectors, alongside electronics and fission-related technologies.
Techniques developed for the handling, separation and management of hydrogen isotopes can support the production of valuable medical isotopes used in diagnostic imaging and cancer treatment.
This suggests that some of the intellectual property being developed to address fusion fuel-cycle challenges could create commercial value long before fusion electricity generation becomes widespread.
Figure 5: 9-year trend (2016-2024) - tritium priority filings by application sector
The competitive landscape reflects this shift. The tritium ecosystem has evolved from one historically influenced by oil and gas towards one increasingly defined by fusion fuel-cycle technologies. Healthcare-related patenting has continued to grow, while oil and gas activity has declined as organisations such as Halliburton have reduced their involvement.
Figure 6: 9-year trend (2016-2024) - top filers in tritium breeding, extraction, processing and monitoring
The tritium landscape has also become more fusion-centric since 2018. Companies with fusion as their primary focus accounted for approximately 53% of patent families in 2024, recovering from a low of 38% in 2018.
Figure 7: 9-year trend (2016-2024) - share of tritium patent families filed by companies with fusion as their primary focus
Importantly, this growth is not being driven by a single dominant filer. National laboratories, universities, public-sector organisations, private fusion companies and start-ups are all contributing to innovation in the field.
Examples are already emerging of fusion companies exploiting these technologies beyond energy generation. Astral Systems, for example, is leveraging fusion-driven neutron technologies in isotope production, demonstrating how innovations developed on the path to fusion energy can create commercial opportunities in healthcare and industrial applications before fusion power itself becomes a commercial reality.
High-temperature superconducting magnets
Tokamaks rely on extremely strong magnetic fields to confine plasma and control its motion. HTS materials, such as REBCO tapes, can operate at higher temperatures than conventional superconductors while enabling significantly stronger magnetic fields, allowing the development of more compact and powerful magnetic systems.
HTS magnet patent activity has remained comparatively stable over the last twenty years, with 184 filings in 2024 broadly in line with historical levels. Nevertheless, the competitive composition of this field appears to be changing.
Figure 8: 10-year trend (2015-2024) - global priority filings in HTS magnets by year
In the medical sector, HTS magnets have the potential to improve MRI systems and other imaging technologies. In energy infrastructure, superconducting cables and magnetic systems may enhance grid efficiency, stability and power-transmission capacity.
Their potential applications also extend into particle accelerators, motors and other advanced industrial systems.
Figure 9: 10-year trend (2015-2024) - top filers in HTS magnets
Fusion has become an increasingly important driver of innovation in this field.
Tokamak Energy has increased its annual patent filings from seven families in 2015 to 27 families in 2024 and is now among the most active organisations, while historically prominent players such as Siemens, GE and AMSC have reduced their activity.
However, the wider sector breakdown demonstrates that HTS innovation remains highly diversified.
Figure 10: share of HTS magnet patent families by organisation type
Fusion companies account for only around 9% of HTS magnet patent families, similar to the contribution from healthcare and medical imaging organisations and comparable with activity from electronics and semiconductor companies.
Electrical equipment, power engineering and specialist superconductivity companies continue to account for a larger share of overall activity.
From our review of recent filings, we also note that fusion organisations are increasingly protecting HTS innovations with multiple end uses in mind. Patent applications from both academic spin-outs and fusion companies frequently include claims or embodiments covering MRI systems, particle accelerators, power-transmission systems and medical devices alongside fusion reactors.
This approach broadens potential licensing opportunities and reflects growing recognition that HTS magnet technologies have pathways to commercialisation outside fusion.
The trend is also reflected in collaboration activity. Tokamak Energy's work with data-centre infrastructure specialist The BE Company illustrates how fusion-derived superconducting technologies are being assessed for applications linked to AI-driven growth in data-centre power demand and efficiency.
Commercial interpretation
The clearest commercial signal is that value in fusion innovation is emerging from enabling technologies rather than reactor deployment alone.
Many of the technologies required to solve fusion's most difficult engineering challenges already have identifiable applications in established commercial sectors.
Plasma control and diagnostics have clear relevance to semiconductor processing and electric spacecraft propulsion. Tritium handling technologies have applications in isotope production, radiopharmaceuticals and specialist nuclear technologies. HTS magnets offer opportunities in medical imaging, power transmission, data centres and advanced industrial systems.
The patent evidence suggests that these adjacent markets may provide earlier routes to commercialisation than fusion electricity generation. Semiconductor equipment suppliers already dominate plasma patenting, healthcare organisations continue to expand their presence in tritium technologies, and HTS magnet innovation attracting organisations spanning energy, healthcare and electronics.
The data also indicates growing opportunities for collaboration. Fusion companies are increasingly filing patents that support multiple implementation routes, entering partnerships with organisations outside the energy sector and developing technologies with broader industrial relevance. Viewed in this way, fusion companies can increasingly be regarded as developers of platform technologies rather than exclusively future energy providers.
For businesses and IP professionals, this suggests that commercially valuable intellectual property may increasingly be found at the intersection of fusion, healthcare, advanced manufacturing, semiconductors and energy infrastructure.

When developing patent strategies, applicants may benefit from focusing on the underlying technical advance rather than solely on a specific fusion implementation.
Demonstrating utility across multiple sectors may support broader protection, increase licensing potential and create a wider range of commercialisation opportunities."
Looking ahead Over the next 12 months, three trends are likely to shape fusion-related innovation and patenting:
- Fuel-cycle innovation is likely to keep growing. Tritium priority filings reached 77 in 2024, their highest level since 2005, and fusion-focused companies filed around 53% of families. Continued investment in fuel-cycle technologies is likely, although commercial opportunities may increasingly emerge through healthcare, isotope production and related sectors
- Specialist fusion companies are likely to keep gaining ground in HTS magnets. Total filings have been stable (184 in 2024), but Tokamak Energy’s continued growth suggests that fusion is becoming an increasingly important driver of HTS innovation. At the same time, the strongest commercial opportunities may arise in healthcare, energy infrastructure, advanced computing and industrial applications rather than fusion alone
- Cross-sector filing is likely to continue. Plasma technology remains dominated by semiconductor equipment suppliers, while healthcare, electronics and aerospace continue to appear alongside fusion in related patent landscapes. As a result, future innovation activity may be characterised less by the growth of isolated fusion ecosystems and more by increasing overlap between fusion and adjacent industries.
Patent activity cannot predict commercial success, but it shows where organisations are investing in innovation. As the sector matures, success is likely to depend not only on progress towards commercial fusion power, but also on the ability to translate fusion-derived technologies into licensing opportunities, strategic partnerships and spin-out businesses serving a broader range of markets.
Meet the attorneys

